Targovax
Trending Articles
Related Content
Finance
Targovax announces appointment of Erik Digman Wiklund as Chief Financial Officer
Targovax ASA, a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that Erik Digman Wiklund has been appointed as the Company’s new Chief Financial Officer, and will take up this role in April 2017